Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Armata Pharmaceuticals ( (ARMP) ) has shared an update.
Armata Pharmaceuticals has reached a separation agreement with its Chief Medical Officer, Dr. Mina Pastagia, effective November 13, 2024. Dr. Pastagia will receive her base salary for 12 months in exchange for releasing claims against the company, contingent on her compliance with the agreement terms.
Learn more about ARMP stock on TipRanks’ Stock Analysis page.